CLEC4E and cancer: CAF09b (which contains poly(I:C) in TDB/DDA liposomes) has also shown promising results in Phase 1 clinical trials for prostate and solid cancers, while more recent studies have demonstrated the potential of chimeric Mincle-targeting anti-cancer vaccines using carbohydrate epitopes as the neoantigen.